JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Ohkawa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Ohkawa, M.
Journal of Nuclear Medicine Vol. 44 No. 12 1905-1910
© 2003 by Society of Nuclear Medicine


Clinical Investigations

Clinical Usefulness of Fusion of 131I SPECT and CT Images in Patients with Differentiated Thyroid Carcinoma

Yuka Yamamoto, MD, Yoshihiro Nishiyama, MD, Toshihide Monden, Yoshitaka Matsumura, Katashi Satoh, MD and Motoomi Ohkawa, MD

Department of Radiology, Faculty of Medicine, Kagawa Medical University, Kagawa, Japan

Precise localization of the foci of 131I uptake for management of patients with differentiated thyroid carcinoma can be difficult because of a lack of anatomic landmarks. The objective of the present study was to demonstrate the clinical usefulness of 131I SPECT/CT fusion images in patients with differentiated thyroid carcinoma. Methods: CT and SPECT were performed 7 d after administration of a therapeutic dose of 131I to 17 patients with differentiated thyroid carcinoma. External markers were placed at 3 locations on the skin of the patient to adjust the sections of CT and SPECT in the same geometric plane. Fusion images were constructed by combining the digital CT and SPECT images on a computer workstation. The data from both planar and SPECT 131I images and CT images were first separately assessed by 2 nuclear medicine physicians. 131I SPECT/CT fusion images were then interpreted. Fusion images were considered to improve image interpretation in comparison with CT and scintigraphy separately when they provided better localization of sites of increased radiopharmaceutical uptake. Results: Both CT and 131I SPECT showed the pathologic sites in 5 of 17 patients (29%). Fusion images were considered to be of benefit in 15 of 17 patients (88%). In 4 patients, CT showed normal-sized lymph nodes, whereas 131I SPECT showed abnormal findings. In 3 patients with bone metastasis, fusion images confirmed the precision of the localization of abnormal 131I uptake. Five bone metastases and 1 muscle metastasis were occult and were not seen on the CT images. Finally, 131I scintigraphy findings were abnormal for 2 patients for whom the CT findings were initially considered normal. Fusion images confirmed the precision of the localization of physiologic 131I uptake. Conclusion: For registration of anatomic and functional images in fusion imaging, the method using external markers was simple and practical. 131I SPECT/CT fusion images using this technique may improve anatomically limited interpretation of 131I scintigraphy alone in patients with differentiated thyroid carcinoma.

Key Words: 131I • CT • fusion image • thyroid carcinoma




This article has been cited by other articles:


Home page
JNMHome page
A. K. Buck, S. Nekolla, S. Ziegler, A. Beer, B. J. Krause, K. Herrmann, K. Scheidhauer, H.-J. Wester, E. J. Rummeny, M. Schwaiger, et al.
SPECT/CT
J. Nucl. Med., August 1, 2008; 49(8): 1305 - 1319.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C. N. Patel, F. U. Chowdhury, and A. F. Scarsbrook
Clinical Utility of Hybrid SPECT-CT in Endocrine Neoplasia
Am. J. Roentgenol., March 1, 2008; 190(3): 815 - 824.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. Even-Sapir, G. Flusser, H. Lerman, G. Lievshitz, and U. Metser
SPECT/Multislice Low-Dose CT: A Clinically Relevant Constituent in the Imaging Algorithm of Nononcologic Patients Referred for Bone Scintigraphy
J. Nucl. Med., February 1, 2007; 48(2): 319 - 324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Nakahara, N. Shigematsu, M. Fujii, E. Kunieda, T. Suzuki, C. Tanaka, J. Hashimoto, and A. Kubo
Value of CT thallium-201 SPECT fusion imaging over SPECT alone for detection and localization of nasopharyngeal and maxillary cancers.
Am. J. Roentgenol., September 1, 2006; 187(3): 825 - 829.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.